Quillivant XR is an extended-release, liquid formulation of methylphenidate primarily prescribed to manage attention deficit hyperactivity disorder (ADHD). As a central nervous system (CNS) stimulant, it helps improve concentration, reduce hyperactivity, and control impulsive behavior throughout the day, often for up to 12 hours.
For those with ADHD, Quillivant XR can significantly improve daily functioning. However, like other prescription stimulants, it carries a serious risk of misuse and dependency. Although sometimes used off-label for narcolepsy symptoms, Quillivant XR is not FDA-approved for this condition. Other stimulants are specifically approved for narcolepsy treatment.
Classified as a Schedule II controlled substance, Quillivant XR has a high potential for abuse, especially among teens, college students, and professionals seeking increased alertness, productivity, or recreation.
Stimulant abuse, including misuse of ADHD medications like Quillivant XR, is a growing concern. A 2025 study found that 7.5% of U.S. adults aged 18 to 64 used prescription stimulants such as methylphenidate between 2021 and 2022, and over one in four admitted to misuse. Nearly 10% met criteria for prescription stimulant use disorder (PSUD). Among misusers, 70% had no prescription, and over 20% developed full-blown addiction.
Quillivant XR addiction affects people from all walks of life. Whether a student under pressure or a professional facing heavy demands, ADHD medication misuse can lead to serious consequences. Recognizing the warning signs and health risks of stimulant misuse is crucial for early intervention.
Early identification of methylphenidate addiction increases recovery chances. This guide explores the causes, signs, and side effects of Quillivant XR misuse and offers support for those facing difficulties.
If you’re dealing with ADHD medication misuse, you’re not alone. Help is available. RehabNet offers a free, confidential helpline to connect you with trusted treatment resources when you’re ready to begin recovery.
